Dupilumab-Associated Head and Neck Dermatitis With Ocular Involvement in a Ten-Year-Old With Atopic Dermatitis: A Case Report and Review of the Literature
Facial and neck erythema secondary to dupilumab use is a side effect not reported in clinical trials; however, it has been reported aftermarket initially in adults and most recently in...
This is the youngest known case of dupilumab-associated HND and conjunctivitis. Overall, oral antifungals appear effective for treating pediatric patients with dupilumab-associated HND. Additionally, topical antifungal therapy may have a role in maintenance therapy.
-
Atopic Dermatitis Connect4yrKey Points • Source: Cureus • Relevance: “A ten-year-old boy with a history of severe AD ongoing since infancy presented to the allergy clinic for disease management. His AD had been refractory to several Show More
Atopic dermatitis: time for tailored therapy
Source : https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)01331-9/fulltext
Atopic dermatitis represents the most frequent chronic inflammatory skin disease, affecting up to 7% of adults and 25% of children.1 The pathogenesis includes inflammation, skin barrier dysfunction, dysbiosis, and modulation...
The conventional treatment of moderate-to-severe atopic dermatitis is based on systemic immunosuppressants or corticosteroids, which might provoke substantial side-effects. As a consequence, the development of well tolerated immunomodulators has resulted in an improvement of the quality of life of patients.
Factors Determining Severity of Atopic Dermatitis Observed
Source : https://www.physiciansweekly.com/factors-determining-severity-of-atopic-dermatitis-observed
Knowledge of clinical signs and patient characteristics with severe AD can help physicians anticipate the course of the disease and focus on targeting management. As one of the most common...
Severity determinants in Finnish patients seem to be early-onset, male sex, smoking, overweight, concomitant asthma, palmar hyperlinearity, hand dermatitis and high IgE-levels.
View of Contrasting between Atopic Dermatitis and Psoriasis in the Quality of Life Impact and the Prevalence of Psychiatric Disorders
Source : https://jofskin.org/index.php/skin/article/view/1624/pdf
Return to Article Details Contrasting between Atopic Dermatitis and Psoriasis in the Quality of Life Impact and the Prevalence of Psychiatric Disorders
In this paper, going beyond the quality of life measures such as dermatology quality of life index (DLQI), the authors have reviewed available medical literature regarding contrasting between AD and PSO.
Maternal antenatal vitamin D supplementation and offspring risk of atopic eczema in the first 4 years of life: evidence from a randomised controlled trial - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/35763390/
Our data provide the first randomised controlled trial evidence of a protective effect of antenatal cholecalciferol supplementation on risk of infantile atopic eczema, with the effect potentially being via increased...
Conclusion: Our data provide the first randomised controlled trial evidence of a protective effect of antenatal cholecalciferol supplementation on risk of infantile atopic eczema, with the effect potentially being via increased breast milk cholecalciferol levels.
-
Atopic Dermatitis Connect4yrKey Points • Source: British Journal of Dermatology • Relevance: “Our data provide the first randomised controlled trial evidence of a protective effect of antenatal cholecalciferol supplementation on risk of infantile atopic eczema, with Show More